Observational secukinumab data reflect clinical trial results in patients with moderate to severe psoriasisNovember 9, 2019Psoriatic Arthritis
New psoriatic patients may have lower serious infection risk with IL-12/23 inhibitionNovember 6, 2019Psoriatic Arthritis
No infection increase seen with biologics in older psoriasis patientsOctober 29, 2019Psoriatic Arthritis
Liver abnormalities, disease common in patients with psoriatic arthritisOctober 24, 2019Psoriatic Arthritis
Ankylosing spondylitis, axial PsA may be two different diseasesOctober 15, 2019Ankylosing spondylitisPsoriatic Arthritis
Psoriasis registry data provide evidence that adalimumab reduces mortalityOctober 14, 2019Psoriatic Arthritis
Prior authorizations for infusibles cause delays, toxicitiesSeptember 26, 2019Rheumatoid ArthritisLupus & Connective Tissue DiseasesSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Long-term advantages may not endure after early tight control in psoriatic arthritisSeptember 11, 2019Psoriatic Arthritis
Cannabidiol may interact with rheumatologic drugsSeptember 3, 2019Rheumatoid ArthritisPainOsteoarthritisLupus & Connective Tissue DiseasesAnkylosing spondylitisSpondyloarthropathiesPsoriatic Arthritis
EULAR updates vaccination recommendations for autoimmune inflammatory rheumatic disease patientsAugust 22, 2019Ankylosing spondylitisLupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
PROMIS tools provide useful data for managing rheumatology patientsAugust 12, 2019Psoriatic ArthritisRheumatoid ArthritisOsteoarthritisLupus & Connective Tissue DiseasesAnkylosing spondylitisSpondyloarthropathiesPediatrics
